Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.50
Ask: 9.00
Change: 0.81 (10.20%)
Spread: 0.50 (5.882%)
Open: 8.25
High: 8.75
Low: 8.25
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MicroSalt files New Patent to Improve Baked Goods

7 Sep 2023 07:00

RNS Number : 6201L
Tekcapital plc
07 September 2023
 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

7 September 2023

Tekcapital Plc

("Tekcapital")

 

MicroSalt® files New Patent to Improve Baked Goods

 

Tekcapital Plc (AIM: TEK) the UK intellectual property investment group focused on creating valuable products that can improve people's lives, is pleased to announce that its portfolio company Microsalt Ltd ("Microsalt") has filed a new patent application (# 63/580,590) entitled "Compositions and methods for reduced leavening time and sodium content in doughs comprising micron-sized salt particles adhered to a carrier," to improve baked goods.

Highlights:

· MicroSalt has recently demonstrated the successful utilisation of its proprietary low-sodium technology with a new recipe for use in baked goods

· There is significant global demand for reducing sodium in a wide variety of baked goods

· MicroSalt believes its new low sodium recipe reduces both sodium content and baking time for baked goods, enabling an improved nutritional profile coupled with a more sustainable and cost-effective production process

Rick Guiney, CEO of MicroSalt®, commented:

"We are very excited about our new invention which we believe enables the production of baked goods quicker, less expensively, and with reduced sodium. The bread market is extremely compelling for us, with global volumes expected to reach 216.7bn kg by 2028[1]. Our ability to not only reduce sodium but to enable a more efficient production process could be a watershed moment in the fight against excess sodium consumption, and we have already seen a high level of interest from one of the world's largest food companies."

 

Market Size

According to Statista the global bread market is estimated to be valued at US$0.5tn in 2023 and is expected to grow annually by 6.83% (CAGR 2023-2028).[2] MicroSalt believe that its new technology can be utilised on a wide variety of baked products to significantly reduce their current sodium concentrations. Potential product applications are listed below.

 

Common Types of Bread (2 slices/serving)[3]

Sodium Content (mg) per serving

 White Bread

340

 Whole Wheat Bread

276

 Rye Bread

422

 Multigrain Bread

253

 Sourdough Bread

304

 Mixed Grain Bread

253

 Marble Rye and Pumpernickel Bread

346

 White with Whole Wheat Swirl Bread

314

 

Reduced Calorie Bread (2 slices/serving)

 Wheat Bread

235

 White Bread

208

 Multigrain Bread

158

 Rye Bread

211

 

Other Bread Varieties (2 slices/serving)

 Cracked Wheat Bread

269

 Italian Bread

234

 Oatmeal Bread

323

 Raisin Bread

203

 Wheat Bran Bread

350

Rolls and Buns (1 roll/serving)

 

 Dinner Roll

146

 Wheat Dinner Roll

95

 Egg Dinner Roll

191

 French Roll

231

 Hamburger or Hotdog Roll

206

 Mixed Grain Hamburger or Hotdog Roll

197

 

According to the U.S. Food and Drug Administration ("FDA"), 2,300 mg/day is the maximum recommended sodium consumption for healthy adults.[4] By reference, a single serving of white bread currently exceeds 14% of the daily maximum recommended consumption of sodium.

 

About MicroSalt

MicroSalt is dedicated to innovating food technology solutions that enable people to live longer, healthier, and happier lives. Its patented low-sodium salt delivers natural salt with approximately 50% less sodium and may be used by both consumers and food manufacturers who wish to decrease the amount of sodium in their food. MicroSalt is 100% natural, non-GMO, gluten free, Kosher and contains no potassium chloride. To learn more about MicroSalt and MicroSalt® products, please visit www.microsalt.co.

Tekcapital owns 97% of the share capital of MicroSalt Ltd. and 6,034,683 shares (78%) of MicroSalt Inc., its U.S. subsidiary.

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

 Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon

microsalt@flagstaffcomms.com

 

+44 (0)207 129 1474

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving MicroSalt and/or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of MicroSalt and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of MicroSalt or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither MicroSalt nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.


[1] https://www.statista.com/outlook/cmo/food/bread-cereal-products/bread/worldwide#:~:text=In%20the%20Bread%20market%2C%20volume,growth%20of%203.9%25%20in%202024.

 

[2] https://www.statista.com/outlook/cmo/food/bread-cereal-products/bread/worldwide#:~:text=Revenue%20in%20the%20Bread%20market,US%2472bn%20in%202023).

 

[3] https://www.fatsecret.com/calories-nutrition/food/bread/sodium

 

[4] https://www.fda.gov/media/84261/download#:~:text=Americans%20eat%20on%20average%20about,1%20teaspoon%20of%20table%20salt

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSWFMMEDSESU
Date   Source Headline
2nd Oct 20187:01 amRNSGuident Ltd Appoints Chairman
2nd Oct 20187:00 amRNSPlacing to raise approximately $1.15million
17th Sep 20187:00 amRNSBelluscura PLC Expands its Patent Portfolio
7th Sep 20187:00 amRNSAppointment of Joint Broker
21st Aug 20182:04 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSMarketing & Technology Transfer Hub
3rd Aug 20187:00 amRNSLucyd Pte Ltd. Launches eShop
1st Aug 20187:00 amRNSSalarius Ltd Appoints CEO
4th Jul 20187:00 amRNSLucyd Pte Ltd. Update
29th Jun 20187:00 amRNSChange of Adviser
30th May 201812:53 pmRNSResult of Annual General Meeting
29th May 20187:00 amRNSHolding(s) in Company
22nd May 20187:00 amRNSLucyd Appoints Global Marketing Manager
22nd May 20187:00 amRNSSalarius Ltd Appoints Directors
17th May 20187:00 amRNSPrivate Placement for Belluscura plc
15th May 20181:17 pmRNSHolding(s) in Company
10th May 20187:00 amRNSHolding(s) in Company
8th May 20187:00 amRNSUniversity Technology Commercialization Programme
4th May 20181:45 pmRNSFinal Results
19th Apr 20187:00 amRNSUK Investor Show
1st Mar 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
14th Feb 20187:00 amRNSPrivate Placement for Belluscura to raise US$1.33m
24th Jan 20187:00 amRNSHolding(s) in Company
22nd Jan 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
18th Dec 20174:14 pmRNSHolding(s) in Company
1st Dec 201710:14 amRNSUpdate re. Belluscura IPO
16th Nov 20178:00 amRNSUpdate re. Belluscura IPO
30th Oct 20177:00 amRNSAcquisition of a Patented AI Valet System
28th Sep 20177:00 amRNSPortfolio Company to Raise Funds via a Token Sale
22nd Sep 20177:00 amRNSInvestor Briefing
31st Jul 20177:00 amRNSHalf-year Report
31st May 201711:18 amRNSResult of AGM
31st May 20177:00 amRNSAcquisition of New Gesture Recognition Technology
9th May 20175:13 pmRNSFinal Results
8th May 20179:11 amRNSNotice of AGM
3rd May 20177:00 amRNSPrivate Placement for Belluscura Ltd
2nd May 20179:31 amRNSApp to Search Global University IP
25th Apr 20177:00 amRNSBelluscura acquires Nanotether Discovery Science
20th Mar 20179:11 amRNSHolding(s) in Company
16th Mar 20179:30 amRNSHolding(s) in Company
10th Mar 20179:31 amRNSExercise of Warrants
3rd Mar 20177:00 amRNSBelluscura Launches Passport Medical Device in US
2nd Mar 20177:00 amRNSBelluscura Ltd Launches Slyde in EU
1st Mar 20177:00 amRNSBelluscura Ltd Launches Wire CaddyT In USA
28th Feb 20177:00 amRNSLicense and Development Agreement
15th Feb 20177:00 amRNSAppointment of Joint Broker
2nd Feb 20179:55 amRNSHolding(s) in Company
1st Feb 20175:25 pmRNSHolding(s) in Company
31st Jan 20174:26 pmRNSTotal Voting Rights and Holding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.